Search Results
(±)-WIN 55,212 (mesylate) 25 mg | Purity Not Available
TargetMol
(±)-WIN 55,212-2 is a potent aminoalkylindole cannabinoid (CB) receptor agonist with a Ki value of 62.3 and 3.3 nM for human recombinant central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, respectively. In contrast, the enantiomer (-)-WIN 55,212-3 acts a partial inverse agonist at CB1 (pIC50 = 5.5) and as a competitive neutral antagonist of CB2, […]
More Information Supplier Page(±)-WIN 55,212 (mesylate)
(±)-WIN 55,212 (mesylate) 50 mg | Purity Not Available
TargetMol
(±)-WIN 55,212-2 is a potent aminoalkylindole cannabinoid (CB) receptor agonist with a Ki value of 62.3 and 3.3 nM for human recombinant central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, respectively. In contrast, the enantiomer (-)-WIN 55,212-3 acts a partial inverse agonist at CB1 (pIC50 = 5.5) and as a competitive neutral antagonist of CB2, […]
More Information Supplier Page(±)-WIN 55,212 (mesylate)
(±)-WS75624B 5 mg | Purity Not Available
TargetMol
(±)-WS75624B is a potent ECE inhibitor (IC50:0.03 μg/mL), a serotonin receptor agonist.
More Information Supplier Page(±)-WS75624B
(±)-WS75624B 50 mg | Purity Not Available
TargetMol
(±)-WS75624B is a potent ECE inhibitor (IC50:0.03 μg/mL), a serotonin receptor agonist.
More Information Supplier Page(±)-WS75624B
(±)-WS75624B 100 mg | Purity Not Available
TargetMol
(±)-WS75624B is a potent ECE inhibitor (IC50:0.03 μg/mL), a serotonin receptor agonist.
More Information Supplier Page(±)-WS75624B
(±)-Z-α-phosphonoglycine trimethyl ester Please inquire | ≥99%
BOC Sciences
Starting material for the synthesis of (Z)-dehydroamino acids by Wittig-Horner reaction with aldehydes; the dehydroamino acids can be stereoselectively reduced to amino acids.
More Information Supplier Page(±)-Zanubrutinib 5mg | Purity Not Available
Selleck Chemicals
(±)-Zanubrutinib ((±)-BGB-3111) is the racemate of Zanubrutinib (HY-101474A). (±)-Zanubrutinib inhibits Bruton’s tyrosine kinase (Btk) with an IC50 of 0.63 nM.
More Information Supplier Page(±)-Zanubrutinib Inquire | 98%
BioChemPartner
(±)-Zanubrutinib 5 mg | 98.19%
TargetMol
(±)-Zanubrutinib is a potent and orally available Bruton’s tyrosine kinase (Btk) inhibitor that demonstrates superior oral bioavailability, achieving higher exposure and more complete target inhibi.
More Information Supplier Page(±)-Zanubrutinib
(±)-Zanubrutinib 10 mg | 98.19%
TargetMol
(±)-Zanubrutinib is a potent and orally available Bruton’s tyrosine kinase (Btk) inhibitor that demonstrates superior oral bioavailability, achieving higher exposure and more complete target inhibi.
More Information Supplier Page(±)-Zanubrutinib